Clinical Studies

Ethos Discovery de novo study Description Sorafenib is a cancer treatment that has been approved for use in human renal cell carcinoma and hepatocellular carcinoma. It has a distinctive inhibitory activity that may be especially valuable at preventing the harmful resistance mechanism known as “evasive resistance” (the promotion of metastasis despite drug activity against the

Research Type Ethos Discovery de novo study Description Rapamycin has an immunosuppressive that has significant anticancer activity. It has been approved for use in several human cancer indications. Anecdotal reports of Rapamycin activity in canine hemangiosarcoma have been made over several years, however its activity has been unpredictable. Recent genomic analysis of hemangiosarcoma in dogs

Research type Ethos Veterinary Health contract research study Description Osteoarthritis is a common condition that affects older dogs. The chronic pain caused by this condition can often be difficult to manage and can require medications that might be contraindicated in geriatric patients. This study is looking to evaluate the pharmacology profile of CBD in dogs

Research Type Ethos Veterinary Health contract research study Description Pancreatitis is a severe condition that affects dogs and can be difficult to diagnose. There are several diagnostics currently available that aid in the diagnosis of pancreatitis, however these have variable sensitivities and specificities. This is study is looking to develop a novel diagnostic test for

Research type Ethos Veterinary Health contract research study Description There are many conditions that can affect pets that cause them to experience chronic pain. For some of these conditions this pain can be difficult to manage with conventional pain medications. This study is evaluating the efficacy of a novel pain medication administered as a nerve